• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲体肝移植与尸体供肝移植治疗小儿代谢性疾病的比较

Living donor liver transplantation for pediatric patients with metabolic disease vs. deceased donation.

机构信息

Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Traditional Chinese Medicine Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Asian J Surg. 2021 Apr;44(4):629-635. doi: 10.1016/j.asjsur.2020.11.016. Epub 2021 Feb 12.

DOI:10.1016/j.asjsur.2020.11.016
PMID:33589337
Abstract

BACKGROUND

There are conflicting reports on the outcomes of patients with metabolic liver disease after liver transplantation. We aimed to compare the outcomes of living donor liver transplantation (LDLT) for metabolic disease vs orthotopic liver transplantation (OLT) from deceased donation.

METHODS

Clinical data of 89 patients undergoing liver transplantation for the treatment of metabolic disorders were reviewed. Pre- and peri-transplant demographics, survival rate, complications and laboratory test data were collected and analyzed.

RESULTS

For the 89 patients, only 2 died by the end of the last follow-up. The post-transplant EAD rate and severe complications were higher for OLT than LDLT. No significant difference was found between LDLT and OLT for the incidence of EBV and CMV infections. In terms of laboratory indexes, the recovery time of PLT, AKP and AST levels were significantly longer for OLT than LDLT. Among different types of metabolic disease, no significant difference was found in viral infection, EAD, laboratory indexes, severe complications or duration of hospital stay.

CONCLUSIONS

LDLT shows a lower incidence rate of EAD and complications, while it also shows a 1-year survival rate and incidence of viral infections compared similar to that of OLT. LDLT is the better treatment option of pediatric liver transplantation for metabolic liver disease compared with OLT.

摘要

背景

代谢性肝病患者肝移植术后结局的报道结果不一。本研究旨在比较活体肝移植(LDLT)与尸体供肝来源的经典原位肝移植(OLT)治疗代谢性疾病的效果。

方法

回顾性分析 89 例行肝移植治疗代谢性疾病患者的临床资料。收集并分析患者术前和围手术期的人口统计学数据、生存率、并发症和实验室检查结果。

结果

89 例患者中,仅 2 例在末次随访时死亡。OLT 的术后急性排斥反应(EAD)发生率和严重并发症发生率高于 LDLT。LDLT 和 OLT 之间 EBV 和 CMV 感染的发生率无显著差异。在实验室指标方面,OLT 的血小板(PLT)、碱性磷酸酶(AKP)和天冬氨酸氨基转移酶(AST)水平的恢复时间明显长于 LDLT。不同类型代谢性疾病之间,病毒感染、EAD、实验室指标、严重并发症或住院时间无显著差异。

结论

LDLT 术后 EAD 及并发症的发生率较低,1 年生存率及病毒感染发生率与 OLT 相似。与 OLT 相比,LDLT 是治疗儿童代谢性肝病的更好选择。

相似文献

1
Living donor liver transplantation for pediatric patients with metabolic disease vs. deceased donation.亲体肝移植与尸体供肝移植治疗小儿代谢性疾病的比较
Asian J Surg. 2021 Apr;44(4):629-635. doi: 10.1016/j.asjsur.2020.11.016. Epub 2021 Feb 12.
2
Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.活体供肝肝移植治疗肝细胞癌:与尸体供肝肝移植的长期结果比较
Transplant Proc. 2009 May;41(4):1283-5. doi: 10.1016/j.transproceed.2009.03.022.
3
Defining long-term outcomes with living donor liver transplantation in North America.界定北美活体供肝移植的长期预后。
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.
4
Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation.在新兴的脑死亡器官捐献框架下活体肝移植的可行性与安全性
Liver Transpl. 2019 Mar;25(3):450-458. doi: 10.1002/lt.25405.
5
Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.活体供肝与死体供肝肝移植:受者发病率和结局的外科医生匹配比较。
Transpl Int. 2013 Aug;26(8):780-7. doi: 10.1111/tri.12127. Epub 2013 Jun 7.
6
Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.单中心成人活体供肝与尸体供肝肝移植(LDLT 与 DDLT):是时候改变我们的肝移植模式了。
Ann Surg. 2019 Sep;270(3):444-451. doi: 10.1097/SLA.0000000000003463.
7
Vascular complications after deceased and living donor liver transplantation: a single-center experience.已故和活体供肝肝移植后的血管并发症:单中心经验
Transplant Proc. 2010 Apr;42(3):865-70. doi: 10.1016/j.transproceed.2010.02.037.
8
Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.活体供肝与尸体供肝肝移植治疗肝细胞癌的长期生存结局:意向治疗和倾向评分匹配分析。
Ann Surg Oncol. 2019 May;26(5):1454-1462. doi: 10.1245/s10434-019-07206-0. Epub 2019 Feb 8.
9
Outcomes of Pediatric Liver Transplantation: Deceased Donor Liver Transplantation vs Living Donor Liver Transplantation.小儿肝移植的结局:尸体供肝肝移植与活体供肝肝移植对比
Transplant Proc. 2018 Dec;50(10):3601-3605. doi: 10.1016/j.transproceed.2018.04.035. Epub 2018 Apr 18.
10
Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.活体供肝移植受者的巨细胞病毒感染对移植后早期结局有显著影响:单中心经验
Transpl Infect Dis. 2018 Aug;20(4):e12905. doi: 10.1111/tid.12905. Epub 2018 May 24.

引用本文的文献

1
Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma and HCV Patients: An Initial Umbrella Review.肝细胞癌合并丙型肝炎病毒患者的活体供肝肝移植与尸体供肝肝移植:一项初步的系统综述。
J Clin Med. 2025 Apr 28;14(9):3047. doi: 10.3390/jcm14093047.